70 likes | 102 Views
CNS-specific antisense oligonucleotides (ASOs) are a class of therapeutic molecules designed to target and modulate gene expression within the central nervous system (CNS). ASOs are short, single-stranded DNA or RNA molecules that can selectively bind to complementary RNA sequences, leading to degradation or modulation of the target RNA.
E N D
GLOBAL CAR T CELL THERAPY MARKET Market Size (2017E) US$ 0.07 BN CAGR (2019–2028) 46.1% Market Size (2028F) US$ 8.5 BN
Segmentation (Scope) By Drug By Indication • Hereditary transthyretin amyloidosis (hATTR) • Approved • Spinal Muscular Atrophy • Patisiran • Huntington’s Disease • Nusinersen • Inotersen • Pipeline • IONIS-HTT Rx (RG6042) © Coherent Market Insights. All Rights Reserved
Key Facts • CNS-specific antisense oligonucleotide (ASO) market is experiencing significant growth due to the rising prevalence of neurological disorders and the increasing demand for targeted therapies. • ASOs are short DNA or RNA molecules designed to specifically bind to messenger RNA (mRNA) and inhibit the production of disease-causing proteins. • The CNS-specific ASO market is driven by the need for effective treatments for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). © Coherent Market Insights. All Rights Reserved
Market Purview • The CNS-specific antisense oligonucleotide (ASO) market is a rapidly growing sector focused on developing targeted therapies for neurological disorders within the central nervous system. • This market involves the development, production, and commercialization of ASOs designed to modulate gene expression and inhibit the production of disease-causing proteins in conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, ALS, and other neurodegenerative disorders. © Coherent Market Insights. All Rights Reserved
Few Leading Companies Alnylam Pharmaceuticals Inc. Sarepta Therapeutics Inc. Biogen Inc. Ionis Pharmaceuticals Inc. © Coherent Market Insights. All Rights Reserved
Global CNS Specific Antisense Oligonucleotide Market (%), By Region, 2023 32.5% ? ? ? ? North America Europe Apac Latin America Middle East © Coherent Market Insights. All Rights Reserved